Study of Tecovirimat for Human Mpox Virus

NCT05534984 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

719

Enrollment

NIH

Sponsor class

Stopped DSMB recommendation due to statistical futility

Conditions

MPOX

Interventions

DRUG: Tecovirimat Oral Capsule
DRUG: Placebo for Tecovirimat
DRUG: Tecovirimat Oral Capsule (Open Label)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]